- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism
Patent holdings for IPC class C12Q 1/6827
Total number of patents in this class: 2485
10-year publication summary
85
|
94
|
224
|
329
|
334
|
304
|
263
|
285
|
275
|
157
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Natera, Inc. | 320 |
58 |
Guardant Health, Inc. | 421 |
48 |
10X Genomics, Inc. | 1209 |
47 |
Illumina, Inc. | 3352 |
40 |
Bio-Rad Laboratories, Inc. | 1614 |
36 |
The Chinese University of Hong Kong | 152 |
34 |
Foundation Medicine, Inc. | 361 |
30 |
Regeneron Pharmaceuticals, Inc. | 4264 |
29 |
The Regents of the University of California | 19918 |
26 |
Massachusetts Institute of Technology | 10057 |
25 |
The Johns Hopkins University | 5667 |
25 |
The Broad Institute, Inc. | 1808 |
25 |
Children's Medical Center Corporation | 1868 |
25 |
Exact Sciences Corporation | 298 |
22 |
President and Fellows of Harvard College | 5976 |
20 |
Grail, Inc. | 214 |
19 |
The Board of Trustees of the Leland Stanford Junior University | 6408 |
18 |
Pacific Biosciences of California, Inc. | 760 |
18 |
Affymetrix, Inc. | 260 |
17 |
Roche Molecular Systems, Inc. | 924 |
17 |
Other owners | 1906 |